Published in PLoS One on November 30, 2009
Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol (2010) 27.58
A call for transparent reporting to optimize the predictive value of preclinical research. Nature (2012) 14.63
Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol (2010) 13.76
On the reproducibility of science: unique identification of research resources in the biomedical literature. PeerJ (2013) 5.11
Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP. Br J Pharmacol (2015) 4.46
Two years later: journals are not yet enforcing the ARRIVE guidelines on reporting standards for pre-clinical animal studies. PLoS Biol (2014) 3.17
Risk of Bias in Reports of In Vivo Research: A Focus for Improvement. PLoS Biol (2015) 2.93
Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research. J Pharmacol Pharmacother (2010) 2.27
The problem of pseudoreplication in neuroscientific studies: is it affecting your analysis? BMC Neurosci (2010) 2.13
Threats to validity in the design and conduct of preclinical efficacy studies: a systematic review of guidelines for in vivo animal experiments. PLoS Med (2013) 1.92
SYRCLE's risk of bias tool for animal studies. BMC Med Res Methodol (2014) 1.72
Principles and standards for reporting animal experiments in The Journal of Physiology and Experimental Physiology. J Physiol (2015) 1.53
Predicting harms and benefits in translational trials: ethics, evidence, and uncertainty. PLoS Med (2011) 1.52
The National Institutes of Health and guidance for reporting preclinical research. BMC Med (2015) 1.48
A systematic review and meta-analysis of the ability of analgesic drugs to reduce metastasis in experimental cancer models. Pain (2015) 1.45
RIGOR guidelines: escalating STAIR and STEPS for effective translational research. Transl Stroke Res (2012) 1.45
The ethical dimension in published animal research in critical care: the public face of science. Crit Care (2014) 1.39
Robust and sensitive analysis of mouse knockout phenotypes. PLoS One (2012) 1.35
Systematic survey of the design, statistical analysis, and reporting of studies published in the 2008 volume of the Journal of Cerebral Blood Flow and Metabolism. J Cereb Blood Flow Metab (2010) 1.35
Progress in using systematic reviews of animal studies to improve translational research. PLoS Med (2013) 1.34
Why animal research needs to improve. Nature (2011) 1.32
Declaration of transparency for each research article. BMJ (2013) 1.27
A meta-analysis of threats to valid clinical inference in preclinical research of sunitinib. Elife (2015) 1.20
Reproducibility of results in preclinical studies: a perspective from the bone field. J Bone Miner Res (2014) 1.20
Improving planning, design, reporting and scientific quality of animal experiments by using the Gold Standard Publication Checklist, in addition to the ARRIVE guidelines. Br J Pharmacol (2011) 1.18
Predictive validity of behavioural animal models for chronic pain. Br J Pharmacol (2011) 1.13
Improving basic and translational science by accounting for litter-to-litter variation in animal models. BMC Neurosci (2013) 1.12
Reporting animal studies: good science and a duty of care. PLoS Biol (2010) 1.07
Whole animal experiments should be more like human randomized controlled trials. PLoS Biol (2013) 1.05
A systematic review of exercise training to promote locomotor recovery in animal models of spinal cord injury. J Neurotrauma (2012) 1.04
Improving the translation of analgesic drugs to the clinic: animal models of neuropathic pain. Br J Pharmacol (2014) 1.03
Improving the reporting of animal research: when will we ARRIVE? Dis Model Mech (2011) 1.02
Survey of Canadian animal-based researchers' views on the Three Rs: replacement, reduction and refinement. PLoS One (2011) 1.02
Open science and reporting animal studies: who's accountable? PLoS Biol (2014) 1.01
Evaluation of social and physical enrichment in modulation of behavioural phenotype in C57BL/6J female mice. PLoS One (2011) 1.00
Environmental enrichment of laboratory rodents: the answer depends on the question. Comp Med (2011) 0.99
Optimising experimental design for high-throughput phenotyping in mice: a case study. Mamm Genome (2010) 0.98
Benefits of histone deacetylase inhibitors for acute brain injury: a systematic review of animal studies. J Neurochem (2010) 0.97
The effects of probiotic supplementation on experimental acute pancreatitis: a systematic review and meta-analysis. PLoS One (2012) 0.97
Methodological Rigor in Preclinical Cardiovascular Studies: Targets to Enhance Reproducibility and Promote Research Translation. Circ Res (2017) 0.96
Effects of MVA85A vaccine on tuberculosis challenge in animals: systematic review. Int J Epidemiol (2015) 0.95
The Gold Standard Publication Checklist (GSPC) for improved design, reporting and scientific quality of animal studies GSPC versus ARRIVE guidelines. Lab Anim (2010) 0.92
Evidence of Experimental Bias in the Life Sciences: Why We Need Blind Data Recording. PLoS Biol (2015) 0.91
Preclinical data reproducibility for R&D--the challenge for neuroscience. Psychopharmacology (Berl) (2015) 0.90
Statistics in experimental cerebrovascular research: comparison of more than two groups with a continuous outcome variable. J Cereb Blood Flow Metab (2010) 0.90
An evaluation of the quality of statistical design and analysis of published medical research: results from a systematic survey of general orthopaedic journals. BMC Med Res Methodol (2012) 0.90
Systematic reviews of animal studies; missing link in translational research? PLoS One (2014) 0.90
Better reporting of scientific studies: why it matters. PLoS Med (2013) 0.90
Applying the ARRIVE Guidelines to an In Vivo Database. PLoS Biol (2015) 0.89
The methodological quality of animal research in critical care: the public face of science. Ann Intensive Care (2014) 0.89
The significance of meaning: why do over 90% of behavioral neuroscience results fail to translate to humans, and what can we do to fix it? ILAR J (2014) 0.88
Quality of Reporting and Adherence to ARRIVE Guidelines in Animal Studies for Chagas Disease Preclinical Drug Research: A Systematic Review. PLoS Negl Trop Dis (2015) 0.87
The usefulness of systematic reviews of animal experiments for the design of preclinical and clinical studies. ILAR J (2014) 0.87
The use of systematic reviews and reporting guidelines to advance the implementation of the 3Rs. J Am Assoc Lab Anim Sci (2015) 0.86
The fallacy of ratio correction to address confounding factors. Lab Anim (2012) 0.86
Reporting of method of animal sacrifice in articles published in Indian journals. J Pharmacol Pharmacother (2011) 0.86
Bias in the reporting of sex and age in biomedical research on mouse models. Elife (2016) 0.86
A combined pre-clinical meta-analysis and randomized confirmatory trial approach to improve data validity for therapeutic target validation. Sci Rep (2015) 0.86
Reporting of preclinical tumor-graft cancer therapeutic studies. Cancer Biol Ther (2012) 0.85
Meta-analyses of animal studies: an introduction of a valuable instrument to further improve healthcare. ILAR J (2014) 0.85
Determinants of the Efficacy of Cardiac Ischemic Preconditioning: A Systematic Review and Meta-Analysis of Animal Studies. PLoS One (2015) 0.85
Reporting of results from animal studies. Environ Health Perspect (2013) 0.84
Statistical considerations for preclinical studies. Exp Neurol (2015) 0.83
The Researchers' View of Scientific Rigor-Survey on the Conduct and Reporting of In Vivo Research. PLoS One (2016) 0.83
Improving the quality of biomedical research: guidelines for reporting experiments involving animals. J Cereb Blood Flow Metab (2011) 0.82
Authorization of Animal Experiments Is Based on Confidence Rather than Evidence of Scientific Rigor. PLoS Biol (2016) 0.82
Introducing Therioepistemology: the study of how knowledge is gained from animal research. Lab Anim (NY) (2017) 0.82
Inclusion of policies on ethical standards in animal experiments in biomedical science journals. J Am Assoc Lab Anim Sci (2011) 0.81
Gait analysis in rats with single joint inflammation: influence of experimental factors. PLoS One (2012) 0.81
Scientific Rigor Recommendations for Optimizing the Clinical Applicability of Translational Research. J Neurol Neurophysiol (2012) 0.81
Ethical reproducibility: towards transparent reporting in biomedical research. Nat Methods (2013) 0.81
Therapeutics targeting Nogo-A hold promise for stroke restoration. CNS Neurol Disord Drug Targets (2013) 0.80
Animal welfare in studies on murine tuberculosis: assessing progress over a 12-year period and the need for further improvement. PLoS One (2012) 0.80
Ensuring transparency and minimization of methodologic bias in preclinical pain research: PPRECISE considerations. Pain (2016) 0.80
The multifactorial role of the 3Rs in shifting the harm-benefit analysis in animal models of disease. Eur J Pharmacol (2015) 0.80
Toward more predictive genetic mouse models of Alzheimer's disease. Brain Res Bull (2015) 0.79
Editorial: preclinical data reproducibility for R&D - the challenge for neuroscience. Springerplus (2015) 0.79
The reproducibility of biomedical research: Sleepers awake! Biomol Detect Quantif (2015) 0.79
Applying refinement to the use of mice and rats in rheumatoid arthritis research. Inflammopharmacology (2015) 0.78
Do bells affect behaviour and heart rate variability in grazing dairy cows? PLoS One (2015) 0.78
Quantitative volumetric imaging of normal, neoplastic and hyperplastic mouse prostate using ultrasound. BMC Urol (2015) 0.78
Adherence to ARRIVE Guidelines in Chinese Journal Reports on Neoplasms in Animals. PLoS One (2016) 0.78
Wound models for periodontal and bone regeneration: the role of biologic research. Periodontol 2000 (2015) 0.78
Designing phenotyping studies for genetically engineered mice. Vet Pathol (2011) 0.78
Practical murine hematopathology: a comparative review and implications for research. Comp Med (2015) 0.78
Established patterns of animal study design undermine translation of disease-modifying therapies for Parkinson's disease. PLoS One (2017) 0.77
Report on a pilot project to introduce a publications officer. CMAJ (2016) 0.77
Increasing efficiency of preclinical research by group sequential designs. PLoS Biol (2017) 0.77
Bedside-to-Bench Translational Research for Chronic Heart Failure: Creating an Agenda for Clients Who Do Not Meet Trial Enrollment Criteria. Clin Med Insights Cardiol (2015) 0.77
Development of a clinically relevant animal model for the talar osteonecrosis in sheep. Int J Med Sci (2012) 0.77
Mixed-strain housing for female C57BL/6, DBA/2, and BALB/c mice: validating a split-plot design that promotes refinement and reduction. BMC Med Res Methodol (2016) 0.76
The importance of early life in childhood obesity and related diseases: a report from the 2014 Gravida Strategic Summit. J Dev Orig Health Dis (2014) 0.76
Show and tell: disclosure and data sharing in experimental pathology. Dis Model Mech (2016) 0.76
The Role of Animal Models in the Study of Hematopoietic Stem Cell Transplantation and GvHD: A Historical Overview. Front Immunol (2016) 0.76
A Critical Look at Biomedical Journals' Policies on Animal Research by Use of a Novel Tool: The EXEMPLAR Scale. Animals (Basel) (2015) 0.76
Improving the predictive value of interventional animal models data. Drug Discov Today (2014) 0.76
A Systematic Review of Rhubarb (a Traditional Chinese Medicine) Used for the Treatment of Experimental Sepsis. Evid Based Complement Alternat Med (2015) 0.76
Standard operating procedures for maintaining cleanliness in a novel compact facility for breeding SPF mice. J Am Assoc Lab Anim Sci (2013) 0.76
Negative animal studies published in Indian Medical Journal: Are they methodologically strong enough to conclude what they are concluding? J Pharm Bioallied Sci (2014) 0.75
Individually specific call feature is not used to neighbour-stranger discrimination: the corncrake case. PLoS One (2014) 0.75
The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med (2001) 37.70
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet (2007) 20.57
Effect size, confidence interval and statistical significance: a practical guide for biologists. Biol Rev Camb Philos Soc (2007) 11.97
Quality of reporting of observational longitudinal research. Am J Epidemiol (2005) 5.25
Guidelines for the design and statistical analysis of experiments using laboratory animals. ILAR J (2002) 3.96
Evidence for the efficacy of NXY-059 in experimental focal cerebral ischaemia is confounded by study quality. Stroke (2008) 3.87
Endorsement of the CONSORT statement by high impact medical journals: survey of instructions for authors. BMJ (2005) 3.65
Emergency medicine animal research: does use of randomization and blinding affect the results? Acad Emerg Med (2003) 3.64
Good laboratory practice: preventing introduction of bias at the bench. Stroke (2008) 3.27
EQUATOR: reporting guidelines for health research. Lancet (2008) 3.15
Assessment of statistical procedures used in papers in the Australian Veterinary Journal. Aust Vet J (1995) 2.88
Do in vivo experimental models reflect human cerebral small vessel disease? A systematic review. J Cereb Blood Flow Metab (2008) 2.45
An assessment of recently published gene expression data analyses: reporting experimental design and statistical factors. BMC Med Inform Decis Mak (2006) 2.29
A systematic review of systematic reviews and meta-analyses of animal experiments with guidelines for reporting. J Environ Sci Health B (2006) 2.23
Reporting animal use in scientific papers. Lab Anim (1997) 2.09
Sample size determination. ILAR J (2002) 1.87
The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection. J Antimicrob Chemother (2007) 1.72
Quality of reporting of diagnostic accuracy studies. Radiology (2005) 1.70
Microbial biodiversity: approaches to experimental design and hypothesis testing in primary scientific literature from 1975 to 1999. Microbiol Mol Biol Rev (2002) 1.66
Animal definition: a necessity for the validity of animal experiments? Lab Anim (2000) 1.63
Specification of laboratory animal use in scientific articles: current low detail in the journals' instructions for authors and some proposals. Methods Find Exp Clin Pharmacol (2005) 1.54
Use of factorial designs to optimize animal experiments and reduce animal use. ILAR J (2002) 1.22
The history of the measurement of ill health. Int J Epidemiol (1972) 1.22
Practical aspects of experimental design in animal research. ILAR J (2002) 1.14
Measuring inconsistency in meta-analyses. BMJ (2003) 128.20
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med (2009) 65.36
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med (2009) 35.37
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ (2009) 34.99
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ (2011) 29.14
CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ (2010) 28.70
Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol (2010) 27.58
Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA (2004) 23.87
CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ (2010) 22.34
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ (2009) 22.18
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med (2009) 21.74
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet (2007) 20.57
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol (2009) 17.92
Animal research: reporting in vivo experiments: the ARRIVE guidelines. Br J Pharmacol (2010) 17.30
CONSORT statement: extension to cluster randomised trials. BMJ (2004) 16.50
CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med (2010) 16.11
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ (2007) 14.52
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol (2008) 14.36
Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med (2008) 13.87
Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS One (2008) 13.32
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg (2010) 12.98
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med (2009) 12.16
Effect size, confidence interval and statistical significance: a practical guide for biologists. Biol Rev Camb Philos Soc (2007) 11.97
Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement. JAMA (2006) 11.87
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol (2009) 11.80
Epidemiology and reporting characteristics of systematic reviews. PLoS Med (2007) 11.51
Better reporting of harms in randomized trials: an extension of the CONSORT statement. Ann Intern Med (2004) 11.47
Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review. Med J Aust (2006) 11.40
Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ (2008) 11.08
Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research. CMAJ (2004) 10.75
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med (2007) 10.43
Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ (2008) 9.98
Reporting recommendations for tumor marker prognostic studies (REMARK). J Natl Cancer Inst (2005) 9.38
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMC Med (2010) 9.30
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ (2013) 9.01
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med (2007) 8.77
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med (2007) 8.46
Developing core outcome sets for clinical trials: issues to consider. Trials (2012) 8.39
Dichotomizing continuous predictors in multiple regression: a bad idea. Stat Med (2006) 8.25
SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med (2013) 8.21
Comparison of registered and published primary outcomes in randomized controlled trials. JAMA (2009) 7.89
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Ann Intern Med (2007) 7.87
A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. J Clin Epidemiol (2009) 7.86
Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ (2014) 7.55
Consort 2010 statement: extension to cluster randomised trials. BMJ (2012) 7.47
Guidance for developers of health research reporting guidelines. PLoS Med (2010) 7.43
Diagnostic tests 4: likelihood ratios. BMJ (2004) 7.33
CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol (2010) 7.04
CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. PLoS Med (2010) 6.88
Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ (2011) 6.80
Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses. BMJ (2003) 6.61
Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls. Lancet (2002) 6.61
Epidemiology and reporting of randomised trials published in PubMed journals. Lancet (2005) 6.55
Reporting recommendations for tumor marker prognostic studies. J Clin Oncol (2005) 6.31
The CARE guidelines: consensus-based clinical case report guideline development. J Clin Epidemiol (2013) 5.93
Adult outcome for children with autism. J Child Psychol Psychiatry (2004) 5.88
CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration. PLoS Med (2008) 5.85
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Epidemiology (2007) 5.77
The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews. BMJ (2010) 5.70
The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed. BMJ (2010) 5.58
No surgical innovation without evaluation: the IDEAL recommendations. Lancet (2009) 5.57
Agreement between methods of measurement with multiple observations per individual. J Biopharm Stat (2007) 5.52
An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study. BMJ (2009) 5.45
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Bull World Health Organ (2007) 5.38
Identifying outcome reporting bias in randomised trials on PubMed: review of publications and survey of authors. BMJ (2005) 5.36
The design of simulation studies in medical statistics. Stat Med (2006) 5.30
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Epidemiology (2007) 5.12
Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension. JAMA (2013) 4.98
Ghost authorship in industry-initiated randomised trials. PLoS Med (2007) 4.95
Quantification of the completeness of follow-up. Lancet (2002) 4.77
Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement. JAMA (2012) 4.73
Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes. JAMA (2010) 4.56
The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med (2015) 4.49
Prognosis and prognostic research: what, why, and how? BMJ (2009) 4.46
An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study. BMJ (2010) 4.46
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. Open Med (2009) 4.43
REporting recommendations for tumor MARKer prognostic studies (REMARK). Breast Cancer Res Treat (2006) 4.42
Prognosis and prognostic research: application and impact of prognostic models in clinical practice. BMJ (2009) 4.38
Prognosis and prognostic research: Developing a prognostic model. BMJ (2009) 4.38
Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane review. Syst Rev (2012) 4.36
Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement. Ann Intern Med (2015) 4.32
Meta-analyses involving cross-over trials: methodological issues. Int J Epidemiol (2002) 4.30
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Prev Med (2007) 4.29
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. Trials (2010) 4.28
CONSORT for reporting randomised trials in journal and conference abstracts. Lancet (2008) 4.20
Endorsement of the CONSORT Statement by high impact factor medical journals: a survey of journal editors and journal 'Instructions to Authors'. Trials (2008) 4.17
Guidelines for the design and statistical analysis of experiments using laboratory animals. ILAR J (2002) 3.96
CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol (2010) 3.96
Developing a prognostic model in the presence of missing data: an ovarian cancer case study. J Clin Epidemiol (2003) 3.90
CONSORT 2010 changes and testing blindness in RCTs. Lancet (2010) 3.68
A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. CMAJ (2009) 3.65
Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT statement. PLoS Med (2010) 3.63
Methods and processes of the CONSORT Group: example of an extension for trials assessing nonpharmacologic treatments. Ann Intern Med (2008) 3.63
Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials. Ann Intern Med (2012) 3.63
CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. Int J Surg (2011) 3.57
Ten steps towards improving prognosis research. BMJ (2009) 3.44